Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII). Both had some major announcements to be made in the past month and the stocks have since shown some very positive upside. Veracyte Inc (NASDAQ VCYT) a molecular diagnostics company pioneering…
Here in this article, we take a look at two very promising Biotech stock: Celldex Therapeutics Inc (NASDAQ CLDX) & Dyax Corp (NASDAQ DYAX). Dyax Corp (NASDAQ DYAX) has had the stock price surge after the company made some major announcements in the past couple of months. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is hoping for similar…
Google Inc (NASDAQ GOOG) and Swiss drugmaker Novartis AG (ADR) have announced an amazing development, one sure to be a significant point of differentiation in Google’s plans to beat Apple Inc (NASDAQ AAPL) and Samsung Electronics Co. Ltd in the race to control consumers healthcare applications.. The product under joint development is “smart” contact lenses….
Kirby’s KEX first-quarter revenue fell 1% from last year. The decline was driven by anemic demand for United’s pressure pumping units, tempered by solid inland trends and improvement in coastal operations. The marine transportation business (75% of first-quarter sales) saw revenue increase 25%, thanks to persistent petrochemical and crude oil shipment demand, which is supporting…
In this article, we take a look at two stocks which have been in news recently, Vertex Pharmaceuticals & Ligand Pharmaceuticals. Keep an eye out for Vertex Pharmaceuticals (NASDAQ VRTX) and Ligand Pharmaceuticals (NASDAQ LGND) . Vertex has performed really well in the recent weeks, recording almost a 50% rise in its price levels. Ligand…
Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Abbvie (NYSE ABBV) and MannKind (NASDAQ MNKD). The two stocks have their fortunes at the opposite end of the spectrum. We take a look at what the future holds for the two stocks. Despite three rejections so far, AbbVie is…
